Related Experiment Video
Updated: Mar 16, 2026

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
Published on: April 1, 2022
Drug-Induced acute Pancreatitis: A Real-World Pharmacovigilance Study Using the Tunisian Databases.
Hiba Ben Hassine1, Faiez Boughanmi1, Abir Lefi2
1Department of Visceral Surgery, Fattouma Bourguiba University Hospital, Faculty of Medicine of Monastir, University of Monastir, 5000 Monastir, Tunisia.
Drug-induced acute pancreatitis (AP) is rare but recognized. This study identified common symptoms and implicated drugs like captopril, atorvastatin, and azathioprine, with most patients experiencing favorable outcomes.
Area of Science:
- Gastroenterology
- Pharmacology
- Clinical Medicine
Background:
- Acute pancreatitis (AP) is an inflammatory pancreatic condition, often linked to gallstones or alcohol.
- Drug-induced AP is an emerging etiology with limited published data.
Purpose of the Study:
- To investigate the epidemiological, clinical, radiological, and management features of drug-induced AP.
- To analyze data from Tunisian databases for drug-associated pancreatitis cases.
Main Methods:
- A retrospective analysis of 13 drug-induced AP cases among 1580 AP patients over five years.
- Data collected included patient demographics, clinical presentation, diagnostic methods, treatments, and outcomes.
Main Results:
- The study identified 13 cases of drug-induced AP, with a mean patient age of 55.62 years and 77% male predominance.
- Common symptoms were epigastric pain (100%) and elevated lipase (92.3%).
- Key implicated drugs included captopril (38.5%), atorvastatin (23.1%), azathioprine (23.1%), metformin, and olanzapine.
Conclusions:
- Drug-induced pancreatitis is a distinct clinical entity necessitating multidisciplinary care.
- Prompt identification and reporting of suspected drug-induced AP are crucial for enhancing pharmacovigilance.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis II: Collaborative Care
Assessment:
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Drug toxicity: Idiosyncratic Reactions

